Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage
Loading
Home›Research›Companies

Companies

Loading
Home›
Research›
Companies›
Immutrix Therapeutics
AddedFeb 16, 2024
UpdatedJun 18, 2026
Immutrix Therapeutics

Immutrix Therapeutics

Angel

Immutrix Therapeutics: Innovating blood cleansing with proprietary tech to remove toxins and mediators.

HQ
Rapid City, SD, US
Founded
2009
Overview
Compare
Fundraising
Employees
Website

Immutrix Therapeutics is a medical technology company based in Rapid City, South Dakota. The company's core mission is to innovate blood cleansing treatments using proprietary adsorbents and smart hollow fiber membranes. Their primary product is a device designed to remove inflammatory mediators and toxins from blood, targeting and binding harmful molecules in a dialysis-like procedure. This technology aims to treat a broad range of medical conditions by modulating and sequestering detrimental molecules from circulation.

Immutrix Therapeutics has made significant strides in the medical tech industry with its innovative approach to blood cleansing. The company's proprietary technology has the potential to revolutionize treatments for various health conditions by effectively removing harmful substances from the bloodstream. Their impact is marked by the development of a unique medical device that offers a novel solution for managing inflammation and toxin-related health issues.

Immutrix Therapeutics - Similar Companies

CytoSorbents logo

CytoSorbents

cytosorbents.com

Path EX logo

Path EX

pathex.co

Intellimedix logo

Intellimedix

Immvention Therapeutix logo

Immvention Therapeutix

ImmuneXcite logo

ImmuneXcite

SeaStar Medical logo

SeaStar Medical

ExThera Medical logo

ExThera Medical

extheramedical.com

ImmuRx logo

ImmuRx

immurx.com

Aethlon Medical logo

Aethlon Medical

aethlonmedical.com

CytoLogic logo

CytoLogic

IM Therapeutics logo

IM Therapeutics

imtherapeutics.com

ICU Metrix logo

ICU Metrix

Imbed Biosciences logo

Imbed Biosciences

imbedbio.com

Ionix Medical logo

Ionix Medical

Velomedix logo

Velomedix

Immutrix Therapeutics - Quick Facts

Who are Immutrix Therapeutics' competitors?

Companies similar to Immutrix Therapeutics include CytoSorbents, Path EX, Intellimedix and Immvention Therapeutix.

When was Immutrix Therapeutics founded?

Immutrix Therapeutics was founded in 2009.

Where is Immutrix Therapeutics' headquarters located?

Immutrix Therapeutics' headquarters is located in Rapid City, SD, US.

When was Immutrix Therapeutics' last funding round?

Immutrix Therapeutics' most recent funding round was for $200k (USD) in November 2017.

How much has Immutrix Therapeutics raised to-date?

As of Nov 27, 2017, Immutrix Therapeutics has raised a total of $3.1M (USD).

How many employees does Immutrix Therapeutics have?

Immutrix Therapeutics has 30 employees as of Feb 5, 2024.

Immutrix Therapeutics - Classification

Industry
  • Hardware
Technology
  • Analytics
Geographic Exposure
  • United States
Revenue
  • Recurring
Customer
  • Enterprise
Main Product
  • Medical Devices
Tags
  • Biotech
  • Healthcare
  • Healthtech
NAICS
  • 620000Health Care and Social Assistance
  • 623000Nursing and Residential Care Facilities
SIC
  • 8000Health Services
  • 8040Offices And Clinics Of Other Health Practitioners
  • 8049Offices And Clinics Of Health Practitioners, Not Elsewhere Classified
Show 16 more industry codes
NAICS
  • 320000Manufacturing
  • 325400Pharmaceutical and Medicine Manufacturing
  • 540000Professional, Scientific, and Technical Services
  • 541714Research and Development in Biotechnology (except Nanobiotechnology)
  • 325000Chemical Manufacturing
  • 541000Professional, Scientific, and Technical Services
  • 541700Scientific Research and Development Services
  • 325410Pharmaceutical and Medicine Manufacturing
  • 541710Research and Development in the Physical, Engineering, and Life Sciences
  • 325412Pharmaceutical Preparation Manufacturing
SIC
  • 2800Chemicals And Allied Products
  • 8700Engineering, Accounting, Research, Management, And Related Services
  • 2830Drugs
  • 8730Research, Development, And Testing Services
  • 2834Pharmaceutical Preparations
  • 8731Commercial Physical and Biological Research